Categories CoronaVirus News Senhwa doses first subject in Phase II Covid-19 drug trial in Taiwan – Clinical Trials Arena Post author By mikenova12@gmail.com Post date November 10, 2023 Listen to this article Senhwa doses first subject in Phase II Covid-19 drug trial in Taiwan Clinical Trials Arena ← WHO updates guidelines on treatments for COVID-19 – who.int → WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines … – World Health Organization